Measuring symptom burden in patients with cancer during a pandemic: the MD Anderson symptom inventory for COVID-19 (MDASI-COVID).

Loretta A WilliamsMeagan S WhisenantTito R MendozaAngela E PeekDonna MalveauxDonna K GriffinDarcy A PonceBruno Palma GranwehrAjay SheshadriKatherine A HutchesonSara M AliSusan K PetersonJohn V HeymachCharles S CleelandIshwaria M Subbiah

Published in: Journal of patient-reported outcomes (2023)

We were able to rapidly develop and electronically launch a PRO measure of COVID-19 symptom burden in patients with cancer. Additional research is needed to confirm the content domain and predictive validity of the MDASI-COVID and define the symptom burden trajectory of COVID-19.

Keyphrases

coronavirus disease
sars cov
respiratory syndrome coronavirus
risk factors
patient reported
anti inflammatory